what semaglutides are approved for weight loss Semaglutide Microdose What's New in Obesity Treatment?

Although tirzepatide shows superior glycaemic and weight outcomes versus semaglutide, the evidence is still concentrated in type 2 diabetes and obesity, leaving uncertainty about whether these advantages translate into better hard outcomes such as cardiovascular events, renal disease progression, and functional preservation (Fras et al., 2021), (Karagiannis et al., 2024), (Aronne et al., 2025)

PlexusDx patients avoid the 2-4 week insurance review periods and can start therapy within days of completing their initial consultation

PMID: 41802484 References are provided for research reference only

These compounds serve different purposes and your choice depends on your primary health goal

The freeze-thaw cycle is notoriously damaging